BIIB033
Monoclonal antibody / From Wikipedia, the free encyclopedia
BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. As of 2015 it was being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis.[1][2][3]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | ? |
Clinical data | |
Other names | Anti-LINGO-1 |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
Close